Sara Bode of Nationwide Children's Hospital in Ohio speaks with NPR's Emily Kwong about why many pediatric centers have started screening kids for literacy skills.

When Lucy Bradley logged on to her NHS app to find out the results of her latest blood test, she didn’t expect to learn that she was suffering from a life-changing kidney condition. The 29-year-old ...

Millions of people in the UK are being urged to complete an NHS test that takes around ten minutes. As NHS London explains, the test could save lives. Posting on X as @NHSEnglandLDN, the health ...

Millions across the UK are being urged to come forward for an NHS test that takes only a few minutes but could help save lives. Taking to X, NHS London highlighted the importance of cervical screening ...

BELOIT — The School District of Beloit Board of Education unanimously approved a $2.5 million offer from the Hendricks Family Foundation to launch a three-year pilot literacy program at one of the ...

Add Yahoo as a preferred source to see more of our stories on Google. -Credit:Reach Publishing Services Limited (Reach Publishing Services Limited) Primary children in West Lothian were among the best ...

Add articles to your saved list and come back to them anytime. Students will be taught consumer and financial literacy earlier in primary school under a plan to bolster declining maths skills across ...

For some children in Columbus, Ohio, reading assessments don't start in the kindergarten classroom -- they happen first in the doctor's office. With concerns rising about lagging childhood literacy ...

People in England could prevent themselves from joining the millions affected by a 'silent killer' through a free test. Most people can access a painless blood pressure check, and it doesn't always ...

Every baby is offered the NHS newborn blood spot test. Midwife Sarah Joy Owen explains how the heel prick works, what conditions it screens for and what happens if further tests are needed. In the ...

A controversial blood test that promises to detect multiple cancers in their early stages failed to meet a key trial endpoint of a significant reduction in stage III-IV cases. Investors in the US ...